Biotech of the week: Vivia Biotech, the Spanish Pioneer in Personalised Medicine

29/01/2016 - 2 minutes

This week we leave the cold winds of Sweden and head south, to warmer weather and say ¡Hola! to Spain and the location for this week, Madrid. This vibrant city is famous for one of the best football teams in the world, the oldest restaurant in the world (opened in 1725!) and is home to the biotech of the week: Vivia Biotech.

 

City: Madrid

Founded: 2007

Employees: 30 (12/2015)

Financial Data: €11.2M Total Raised (as of 12/2015)

CEO: 

Mission: Vivia Biotech has one primary focus and that is personalised medicine, through screening and profiling of thousands of existing drugs directly on a patient’s biological sample, to conclude the best course of action. They achieve this using their technology, Exvitech, which enables ex-vivo analysis of drugs/drug combinations on patient samples within 48 hours.

Vivia Biotech hope to develop a personalised medicine kit for hematologic cancers (e.g. leukemia, lymphoma etc) which will be able to predict the best treatment for each individual.

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!

Support Us

Become a Member